Filing Details
- Accession Number:
- 0000914760-16-000389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-18 14:41:47
- Reporting Period:
- 2016-01-06
- Filing Date:
- 2016-03-18
- Accepted Time:
- 2016-03-18 14:41:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244745 | L Bernard Kasten | C/O Enzo Biochem Inc. 527 Madison Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-01-21 | 2,500 | $4.66 | 40,282 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-10 | 1,857 | $4.40 | 38,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-10 | 9,720 | $4.40 | 28,705 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-10 | 18,651 | $3.47 | 10,054 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-11 | 3,100 | $4.39 | 6,954 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-11 | 6,954 | $4.41 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (to acquire common stock) | Acquisiton | 2016-01-06 | 63,291 | $0.00 | 63,291 | $4.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 257,455 | 2017-01-07 | 2021-01-05 | No | 4 | A | Direct |
Footnotes
- The Reporting Person was granted 63,291 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 7, 2017.
Billionaire Hedge Funds
